As of mid-2024, a full 6% of US adults are actively taking GLP-1 agonists , but the huge potential addressable market for these drugs, combined with an ongoing shortage, means that these medications have plenty of additional potential running room
In the REDEFINE 1 trial, CagriSema produced 20.4% body weight loss over 68 weeks
Clinical data support the use of Ipamorelin as a safe long-term treatment
By partnering with employers, health plans and pharmacy benefit managers (PBMs), the company offers personalized plans, virtual care, at-home lab tests and prescription medication for the chronic conditions outlined above, including delivery
Medications like Ozempic and Wegovy are powerful tools that alter your endocrine system